A 2-month-old Chinese male infant with persistent neonatal jaundice and elevated transaminases was found to carry a heterozygous deletion of exon 3 of the SLC25A13 gene, diagnosed as neonatal intrahepatic cholestasis caused by citrin deficiency.
Medicine · 9 authors, 3 centres
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
A 2-month-old Chinese male infant with persistent neonatal jaundice and elevated transaminases was found to carry a heterozygous deletion of exon 3 of the SLC25A13 gene, diagnosed as neonatal intrahepatic cholestasis caused by citrin deficiency.
This case report describes a 2-month-old male infant who presented with persistent skin yellowing since birth and elevated ALT and AST levels. Diagnostic workup excluded viral hepatitis, drug-induced liver damage, and other causes. Whole exome sequencing at 2 months and 13 days revealed a heterozygous deletion of exon 3 of the SLC25A13 gene, judged pathogenic per ACMG guidelines, confirming citrin deficiency (NICCD). Initial pharmacologic interventions (compound glycyrrhizin, glutathione) did not sustain ALT improvement. By 6 months of age, jaundice resolved and liver function normalized without specific treatment. The patient had growth retardation (length and weight at −2SD). This is the first reported case of citrin deficiency caused by this heterozygous exon deletion mutation.